NCT06771622 2026-02-04Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid TumorsFBD Biologics LimitedPhase 1/2 Active not recruiting500 enrolled
NCT03721679 2021-02-01Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1Oncovir, Inc.Phase 1/2 Terminated7 enrolled